Synthesis and biological evaluation of antifungal derivatives of enfumafungin as orally bioavailable inhibitors of β-1,3-glucan synthase.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 22672801)

Published in Bioorg Med Chem Lett on May 17, 2012

Authors

Brian H Heasley1, Gregory J Pacofsky, Ahmed Mamai, Hao Liu, Kingsley Nelson, Ghjuvanni Coti, Michael R Peel, James M Balkovec, Mark L Greenlee, Paul Liberator, Dongfang Meng, Dann L Parker, Robert R Wilkening, James M Apgar, F Racine, Ming Jo Hsu, Robert A Giacobbe, Jennifer Nielsen Kahn

Author Affiliations

1: Scynexis, Inc., PO Box 12878, Research Triangle Park, NC 27709-2878, USA. brian.heasley@scynexis.com

Articles by these authors

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma. Nat Med (2008) 11.49

CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients. J Clin Invest (2011) 6.38

Inducible apoptosis as a safety switch for adoptive cell therapy. N Engl J Med (2011) 6.14

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. Blood (2009) 4.98

Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species. J Clin Microbiol (2004) 4.70

Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma. Blood (2011) 3.82

Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins. J Clin Oncol (2013) 3.65

Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res (2006) 3.32

Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes. Blood (2009) 3.27

Failure of bone marrow cells to transdifferentiate into neural cells in vivo. Science (2002) 3.18

Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol (2009) 3.04

MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J Biol Chem (2010) 2.85

Translocation of single-stranded DNA through single-walled carbon nanotubes. Science (2010) 2.50

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation. Blood (2009) 2.47

Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels. Nat Commun (2013) 2.31

Workgroup report: workshop on source apportionment of particulate matter health effects--intercomparison of results and implications. Environ Health Perspect (2005) 2.29

11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice. J Exp Med (2005) 2.12

Liver transplantation with donation after cardiac death donors: a comprehensive update. J Surg Res (2012) 2.10

PM source apportionment and health effects: 1. Intercomparison of source apportionment results. J Expo Sci Environ Epidemiol (2006) 2.07

Evidence that an early pregnancy causes a persistent decrease in the number of functional mammary epithelial stem cells--implications for pregnancy-induced protection against breast cancer. Stem Cells (2008) 1.96

Virus-tumor interactome screen reveals ER stress response can reprogram resistant cancers for oncolytic virus-triggered caspase-2 cell death. Cancer Cell (2011) 1.95

Contribution of the tetrodotoxin-resistant voltage-gated sodium channel NaV1.9 to sensory transmission and nociceptive behavior. Proc Natl Acad Sci U S A (2005) 1.84

Accelerated production of antigen-specific T cells for preclinical and clinical applications using gas-permeable rapid expansion cultureware (G-Rex). J Immunother (2010) 1.81

Determination of dual effects of parathyroid hormone on skeletal gene expression in vivo by microarray and network analysis. J Biol Chem (2007) 1.79

Gene discovery in the apicomplexa as revealed by EST sequencing and assembly of a comparative gene database. Genome Res (2003) 1.75

MEK-independent survival of B-RAFV600E melanoma cells selected for resistance to apoptosis induced by the RAF inhibitor PLX4720. Clin Cancer Res (2010) 1.68

Proteomic and cytokine plasma biomarkers for predicting progression from colorectal adenoma to carcinoma in human patients. Proteomics (2013) 1.66

Day hospital versus inpatient management of uncomplicated vaso-occlusive crises in children with sickle cell disease. Pediatr Blood Cancer (2008) 1.62

Simvastatin suppresses lung inflammatory response in a rat cardiopulmonary bypass model. Ann Thorac Surg (2007) 1.57

Clinical outcomes of two different types of open-door laminoplasties for cervical compressive myelopathy: a prospective study. Neurol India (2012) 1.53

CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J Virol (2004) 1.52

MMP-9 and IL-6 are potential biomarkers for disease activity in Takayasu's arteritis. Int J Cardiol (2012) 1.51

Anterior decompression and nonstructural bone grafting and posterior fixation for cervical facet dislocation with traumatic disc herniation. Spine (Phila Pa 1976) (2012) 1.51

Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol. Mol Cancer (2010) 1.50

Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma. J Immunother (2010) 1.50

Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation. Blood (2010) 1.44

12-O-tetradecanoylphorbol-13-acetate (TPA)-induced dual-specificity phosphatase expression and AML cell survival. Leuk Res (2005) 1.40

Laser damage properties of TiO2/Al2O3 thin films grown by atomic layer deposition. Appl Opt (2011) 1.39

Two-stage vertebral column resection for severe and rigid scoliosis in patients with low body weight. Spine J (2012) 1.39

Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant. Mol Ther (2013) 1.38

Gene expression profiling changes induced by a novel Gemini Vitamin D derivative during the progression of breast cancer. Biochem Pharmacol (2006) 1.37

Nucleofection of DCs to generate Multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host. Mol Ther (2009) 1.36

Comparable outcome of alternative donor and matched sibling donor hematopoietic stem cell transplant for children with acute lymphoblastic leukemia in first or second remission using alemtuzumab in a myeloablative conditioning regimen. Biol Blood Marrow Transplant (2008) 1.35

Genetic manipulation of tumor-specific cytotoxic T lymphocytes to restore responsiveness to IL-7. Mol Ther (2009) 1.35

Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism. Cancer Res (2011) 1.35

Near- and far-field aerodynamics in insect hovering flight: an integrated computational study. J Exp Biol (2008) 1.33

Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy. Hum Pathol (2007) 1.33

Two-stage procedure protocol for minimally invasive plate osteosynthesis technique in the treatment of the complex pilon fracture. Int Orthop (2011) 1.32

Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma. Mol Ther (2013) 1.25

Influence of Ni Catalyst Layer and TiN Diffusion Barrier on Carbon Nanotube Growth Rate. Nanoscale Res Lett (2010) 1.24

T cells redirected to EphA2 for the immunotherapy of glioblastoma. Mol Ther (2012) 1.21

Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma. Mol Ther (2013) 1.20

Changes in the expression of human cell division autoantigen-1 influence Toxoplasma gondii growth and development. PLoS Pathog (2006) 1.19

Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PLoS One (2010) 1.17

Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity. Clin Cancer Res (2014) 1.17

Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders. Neurosci Lett (2006) 1.16

Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis. J Immunol (2008) 1.16

Hemivertebrae resection for unbalanced multiple hemivertebrae: is it worth it? Eur Spine J (2013) 1.16

PAP inhibitor with in vivo efficacy identified by Candida albicans genetic profiling of natural products. Chem Biol (2008) 1.15

Aerodynamic performance of a hovering hawkmoth with flexible wings: a computational approach. Proc Biol Sci (2011) 1.15

Sensitivity of RECQL4-deficient fibroblasts from Rothmund-Thomson syndrome patients to genotoxic agents. Hum Genet (2008) 1.15

Effect of vascular endothelial growth factor on rat Achilles tendon healing. Plast Reconstr Surg (2003) 1.14

Steerable catheters in minimally invasive vascular surgery. Int J Med Robot (2009) 1.12

GROalpha is highly expressed in adenocarcinoma of the colon and down-regulates fibulin-1. Clin Cancer Res (2006) 1.12

CNS 7056: a novel ultra-short-acting Benzodiazepine. Anesthesiology (2007) 1.11

Laparoscopic radical cystectomy with orthotopic ileal neobladder for bladder cancer: oncologic results of 171 cases with a median 3-year follow-up. Eur Urol (2010) 1.10

Chemical recognition and binding kinetics in a functionalized tunnel junction. Nanotechnology (2012) 1.09

CCAAT/enhancer binding protein beta regulates stem cell activity and specifies luminal cell fate in the mammary gland. Stem Cells (2010) 1.08

Letters. Spine (Phila Pa 1976) (2015) 1.07

Triazolo-tetrahydrofluorenones as selective estrogen receptor beta agonists. Bioorg Med Chem Lett (2006) 1.07

T cells redirected against CD70 for the immunotherapy of CD70-positive malignancies. Blood (2011) 1.07

Receptor tyrosine kinase ErbB2 translocates into mitochondria and regulates cellular metabolism. Nat Commun (2012) 1.06

Determination and analysis of ustiloxins A and B by LC-ESI-MS and HPLC in false smut balls of rice. Int J Mol Sci (2012) 1.06

Pyrazolo[1,5-a]pyridines as p38 kinase inhibitors. Org Lett (2005) 1.04

A critical assessment of transcranial doppler screening rates in a large pediatric sickle cell center: opportunities to improve healthcare quality. Pediatr Blood Cancer (2008) 1.04

2 GHz passively harmonic mode-locked fiber laser by a microfiber-based topological insulator saturable absorber. Opt Lett (2013) 1.04

Endothelial induction of fgl2 contributes to thrombosis during acute vascular xenograft rejection. J Immunol (2004) 1.03

Association of medical home care and disparities in emergency care utilization among children with special health care needs. Acad Pediatr (2009) 1.03

Expression of X-linked inhibitor of apoptosis protein in human colorectal cancer and its correlation with prognosis. J Surg Oncol (2009) 1.02

Maximum Likelihood Estimations and EM Algorithms with Length-biased Data. J Am Stat Assoc (2011) 1.02

Emerging metabolic targets in cancer therapy. Front Biosci (Landmark Ed) (2011) 1.02

Simulation of hemodynamic responses to the valsalva maneuver: an integrative computational model of the cardiovascular system and the autonomic nervous system. J Physiol Sci (2006) 1.02

Translational regulation of HIV-1 replication by HIV-1 Rev cellular cofactors Sam68, eIF5A, hRIP, and DDX3. J Neuroimmune Pharmacol (2011) 1.01

Small-molecule inhibitor leads of ribosome-inactivating proteins developed using the doorstop approach. PLoS One (2011) 1.01

The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis. Hepatology (2009) 1.01

Effect of Mini-plate Fixation on Hinge Fracture and Bony Fusion in Unilateral Open-door Cervical Expansive Laminoplasty. Clin Spine Surg (2016) 1.01

A hydrogen-bonded electron-tunneling circuit reads the base composition of unmodified DNA. Nanotechnology (2009) 1.01

Measuring wing kinematics, flight trajectory and body attitude during forward flight and turning maneuvers in dragonflies. J Exp Biol (2003) 1.00

Differential Aspergillus lentulus echinocandin susceptibilities are Fksp independent. Antimicrob Agents Chemother (2010) 0.99

Mesoporous LiFePO4/C nanocomposite cathode materials for high power lithium ion batteries with superior performance. Adv Mater (2010) 0.99

Cyclopentenone prostaglandin-induced unfolding and aggregation of the Parkinson disease-associated UCH-L1. Proc Natl Acad Sci U S A (2010) 0.99

Sunitinib malate is active against human urothelial carcinoma and enhances the activity of cisplatin in a preclinical model. Urol Oncol (2008) 0.99

Effects of environmental tobacco smoke on the developing immune system of infant monkeys. J Allergy Clin Immunol (2007) 0.98

miR-10b promotes migration and invasion in nasopharyngeal carcinoma cells. Asian Pac J Cancer Prev (2013) 0.98

Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens. Am J Pathol (2010) 0.98

Body dynamics and hydrodynamics of swimming fish larvae: a computational study. J Exp Biol (2012) 0.98

Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation. Cytotherapy (2011) 0.98